Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen
Tóm tắt
Từ khóa
Tài liệu tham khảo
Adjidé CC . 2010. A sensitive, specific and predictive isolation medium developed for Stenotrophomonas maltophilia study in healthcare settings. Pathol. Biol. (Paris) 58:11–17.
Bajaj N Sheth AN Burgess JJ Husain H Brooke JS . 2009. Disinfectant reduction of biofilm formation of Stenotrophomonas maltophilia, abstr AE4. Abstr. 59th Annu. Conf. Can. Soc. Microbiol. Canadian Society of Microbiologists, Ottawa, Ontario, Canada.
Blondel-Hill E Henry DA Speert DP . 2007. Pseudomonas , p 734–748. In Murray PR Baron EJ Jorgensen JH Landry ML Pfaller MA (ed), Manual of clinical microbiology, 9th ed, vol 1. ASM Press, Washington, DC.
Borovilos M Shulman ST Brooke JS . 2005. Role of flagella in biofilm formation by Stenotrophomonas maltophilia, abstr B2. Abstr. 55th Annu. Conf. Can. Soc. Microbiol. Canadian Society of Microbiologists, Ottawa, Ontario, Canada.
Brooke JS Annand JW Hammer A Dembkowski K Shulman ST . 2009. Investigation of bacterial pathogens on seventy frequently used environmental surfaces in a large urban U.S. university. J. Environ. Health 71:17–22.
Carattoli A . 2003. Plasmid-mediated antimicrobial resistance in Salmonella enterica . Curr. Issues Mol. Biol. 5:113–122.
Caylan R . 2004. An epidemiological analysis of Stenotrophomonas maltophilia strains in a university hospital. Jpn. J. Infect. Dis. 57:37–40.
Clinical and Laboratory Standards Institute. 2009. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A8. CLSI Wayne PA.
Clinical and Laboratory Standards Institute. 2011. Performance standards for antimicrobial susceptibility testing; 21st informational supplement. M100-S21. CLSI Wayne PA.
Cystic Fibrosis Foundation. 2004. Patient registry 2003. Annual data report to the center directors. Cystic Fibrosis Foundation Bethesda MD.
Department of Health. 1993. Ice cubes: infection caused by Xanthomonas maltophilia. Hazard (93)42. Medical Services Directorate Department of Health London United Kingdom.
Gales AC . 2001. Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997–1999). Clin. Infect. Dis. 32:S104–S113.
Hugh R Leifson E . 1963. A description of the type strain of Pseudomonas maltophilia . Int. Bull. Bacteriol. Nomencl. Taxon. 13:133–138.
Husain H Burgess JJ Sheth AN Bajaj NH Brooke JS . 2009. Efficacy of selected germicides on the biofilm formation of Stenotrophomonas maltophilia, abstr AE22. Abstr. 59th Annu. Conf. Can. Soc. Microbiol. Canadian Society of Microbiologists, Ottawa, Ontario, Canada.
Jang TN Wang FD Wang LS Liu CY Liu IM . 1992. Xanthomonas maltophilia bacteremia: an analysis of 32 cases. J. Formos. Med. Assoc. 91:1170–1176.
Korakianitis I Mirtsou V Gougoudi E Raftogiannis M Giamarellos-Bourboulis EJ . 2010. Post-antibiotic effect (PAE) of moxifloxacin in multidrug-resistant Stenotrophomonas maltophilia. 36:387–389.
Kraus D Peschel A . 2006. Molecular mechanisms of bacterial resistance to antimicrobial peptides. Curr. Top. Microbiol. Immunol. 306:231–250.
Lai C-H . 2004. Clinical characteristics and prognostic factors of patients with Stenotrophomonas maltophilia bacteremia. J. Microbiol. Immunol. Infect. 37:350–358.
Liaw S-J Teng L-J Hsueh P-R Ho S-W Luh K-T . 2002. In vitro activities of antimicrobial combinations against clinical isolates of Stenotrophomonas maltophilia . J. Formos. Med. Assoc. 101:495–501.
LiPuma JJ Currie BJ Lum GD Vandamme PAR . 2007. Burkholderia, Stenotrophomonas, Ralstonia, Cupriavidus, Pandoraea, Brevundimonas, Comamonas, Delftia, and Acidovorax , p 749–769. In Murray PR Baron EJ Jorgensen JH Landry ML Pfaller MA (ed), Manual of clinical microbiology, 9th ed, vol 1. ASM Press, Washington, DC.
Reference deleted.
Martinez RF Kopp DR Mangat RK Snouffer AA Brooke JS . 2010. Effect of ferric chloride on biofilm formation of Stenotrophomonas maltophilia, abstr II24. Abstr. 60th Annu. Conf. Can. Soc. Microbiol. Canadian Society of Microbiologists, Hamilton, Ontario, Canada.
Reference deleted.
Palleroni NJ . 2005. Genus IX. Stenotrophomonas Palleroni and Bradbury 1993, 608, p 107–115. In Brenner DJ Krieg NR Staley JT Garrity GM (ed), Bergey's manual of systematic bacteriology, vol 2. Springer Science+Business Media Inc., New York, NY.
Public Health Laboratory Service . 1993. Ice as a source of infection acquired in hospital. CDR Wkly. 3:53.
Rivas R García-Fraile P Mateos PF Martinez-Molina E Velázquez E . 2009. Phylogenetic diversity of fast-growing bacteria isolated from superficial water of Lake Martel, a saline subterranean lake in Mallorca Island (Spain) formed by filtration from the Mediterranean Sea through underground rocks. Adv. Stud. Biol. 1:333–344.
Rocco F De Gregorio E Di Nocera PP . 2010. A giant family of short palindromic sequences in Stenotrophomonas maltophilia . FEMS Microbiol. Lett. 308:185–192.
Ross RA Marzec G . 1984. The bacterial diseases of reptiles. Their epidemiology control diagnosis and treatment p 3 7–10 14–18. Institute for Herpetological Research Stanford University School of Medicine Stanford CA.
Savini V . 2010. Chloramphenicol and rifampin may be the only options against Stenotrophomonas maltophilia. A tale of a colonized bladder device in a patient with myelofibrosis. Infez. Med. 18:193–197.
Schreckenberger PC Daneshvar MI Hollis DG . 2007. Acinetobacter, Achromobacter, Chryseobacterium, Moraxella, and other nonfermentative Gram-negative rods, p 770–802. In Murray PR Baron EJ Jorgensen JH Landry ML Pfaller MA (ed), Manual of clinical microbiology, 9th ed, vol 1. ASM Press, Washington, DC.
Sundaram S Auriemma M Howard G Jr Brandwein H Leo F . 1999. Application of membrane filtration for removal of diminutive bioburden organisms in pharmaceutical products and processes. PDA J. Pharm. Sci. Technol. 53:186–201.
Teng S-O . 2009. Bacterial contamination of patients' medical charts in a surgical ward and the intensive care unit: impact on nosocomial infections. J. Microbiol. Immunol. Infect. 42:86–91.
Tungekar R Zuniga M Brooke JS . 2006. Investigation of a Stenotrophomonas maltophilia mutant that produces more biofilm than its parental isolate, abstr B-071. Abstr. 106th Gen. Meet. Am. Soc. Microbiol. American Society for Microbiology, Washington, DC.
Vo A Davis N Watts P Brooke JS . 2005. Characterization of a Stenotrophomonas maltophilia mutant that produces excessive biofilm on abiotic surfaces, abstr B-1273. In Abstr. Joint Meet. 3 Div. Int. Union Microbiol. Soc. American Society for Microbiology, Washington, DC.
Wang W-S Liu C-P Lee C-M Huang F-Y . 2004. Stenotrophomonas maltophilia bacteremia in adults: four years' experience in a medical center in northern Taiwan. J. Microbiol. Immunol. Infect. 37:359–365.
Wu P-S . 2006. Stenotrophomonas maltophilia bacteremia in pediatric patients—a 10 year analysis. J. Microbiol. Immunol. Infect. 39:144–149.
Yorioka K Oie S Kamiya A . 2010. Microbial contamination of suction tubes attached to suction instruments and preventive methods. Jpn. J. Infect. Dis. 63:124–127.